Literature DB >> 30994337

Differential Recognition of Diet-Derived Neu5Gc-Neoantigens on Glycan Microarrays by Carbohydrate-Specific Pooled Human IgG and IgA Antibodies.

Shani Leviatan Ben-Arye1, Christoph Schneider2, Hai Yu3, Salam Bashir1, Xi Chen3, Stephan von Gunten2, Vered Padler-Karavani1.   

Abstract

Sialic acids (Sias) cover vertebrate cell surface glycans. N-Acetylneuraminic acid (Neu5Ac) and its hydroxylated form N-glycolylneuraminic acid (Neu5Gc) are common Sia in mammals. Humans cannot synthesize Neu5Gc but accumulate it on cells through red-meat rich diets, generating numerous immunogenic Neu5Gc-neoantigens. Consequently, humans have diverse anti-Neu5Gc antibodies affecting xenotransplantation, cancer, atherosclerosis, and infertility. Anti-Neu5Gc antibodies circulate as IgG, IgM, and IgA isotypes; however, repertoires of the different isotypes in a large population have not been studied yet. Here, we used glycan microarrays to investigate anti-Neu5Gc IgGs and IgAs in intravenous immunoglobulin (IVIG) or pooled human IgA, respectively. Binding patterns on microarrays fabricated with Neu5Gc- and Neu5Ac-glycans, together with inhibition assays, revealed that different IVIG preparations have highly specific anti-Neu5Gc IgG reactivity with closely related repertoires, while IgAs show cross-reactivity against several Neu5Ac-glycans. Such different anti-Neu5Gc IgG/IgA repertoires in individuals could possibly mediate distinctive effects on human diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30994337      PMCID: PMC6756923          DOI: 10.1021/acs.bioconjchem.9b00273

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  54 in total

1.  Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs.

Authors:  Apolline Salama; Gwénaëlle Evanno; Noha Lim; Juliette Rousse; Ludmilla Le Berre; Arnaud Nicot; Jean-Marie Bach; Sophie Brouard; Kristina M Harris; Mario R Ehlers; Stephen E Gitelman; Jean-Paul Soulillou
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

Review 2.  Role of IgA and IgA fc receptors in inflammation.

Authors:  Renato C Monteiro
Journal:  J Clin Immunol       Date:  2009-10-16       Impact factor: 8.317

Review 3.  IVIG-mediated effector functions in autoimmune and inflammatory diseases.

Authors:  Caroline Galeotti; Srini V Kaveri; Jagadeesh Bayry
Journal:  Int Immunol       Date:  2017-12-30       Impact factor: 4.823

Review 4.  Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.

Authors:  Peter J Späth; Christoph Schneider; Stephan von Gunten
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-09-16       Impact factor: 4.291

5.  Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies.

Authors:  Oliver M T Pearce; Heinz Läubli; Andrea Verhagen; Patrick Secrest; Jiquan Zhang; Nissi M Varki; Paul R Crocker; Jack D Bui; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

6.  Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.

Authors:  Darius Ghaderi; Rachel E Taylor; Vered Padler-Karavani; Sandra Diaz; Ajit Varki
Journal:  Nat Biotechnol       Date:  2010-07-25       Impact factor: 54.908

7.  Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.

Authors:  Rachel E Taylor; Christopher J Gregg; Vered Padler-Karavani; Darius Ghaderi; Hai Yu; Shengshu Huang; Ricardo U Sorensen; Xi Chen; Jaime Inostroza; Victor Nizet; Ajit Varki
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

8.  N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution.

Authors:  Maria Hedlund; Pam Tangvoranuntakul; Hiromu Takematsu; Jeffrey M Long; Gary D Housley; Yasunori Kozutsumi; Akemi Suzuki; Anthony Wynshaw-Boris; Allen F Ryan; Richard L Gallo; Nissi Varki; Ajit Varki
Journal:  Mol Cell Biol       Date:  2007-04-09       Impact factor: 4.272

Review 9.  Glycan microarrays: powerful tools for biomarker discovery.

Authors:  Saddam M Muthana; Jeffrey C Gildersleeve
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

10.  Presentation Mode of Glycans Affect Recognition of Human Serum anti-Neu5Gc IgG Antibodies.

Authors:  Salam Bashir; Shani Leviatan Ben Arye; Eliran Moshe Reuven; Hai Yu; Cristina Costa; Manuel Galiñanes; Tomaso Bottio; Xi Chen; Vered Padler-Karavani
Journal:  Bioconjug Chem       Date:  2018-12-13       Impact factor: 4.774

View more
  5 in total

Review 1.  The Structural Complexity and Animal Tissue Distribution of N-Glycolylneuraminic Acid (Neu5Gc)-Terminated Glycans. Implications for Their Immunogenicity in Clinical Xenografting.

Authors:  Michael E Breimer; Jan Holgersson
Journal:  Front Mol Biosci       Date:  2019-07-19

Review 2.  Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.

Authors:  Sharon Yehuda; Vered Padler-Karavani
Journal:  Front Immunol       Date:  2020-01-23       Impact factor: 7.561

3.  The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration.

Authors:  Thomas Senage; Anu Paul; Thierry Le Tourneau; Imen Fellah-Hebia; Marta Vadori; Salam Bashir; Manuel Galiñanes; Tomaso Bottio; Gino Gerosa; Arturo Evangelista; Luigi P Badano; Alberto Nassi; Cristina Costa; Galli Cesare; Rizwan A Manji; Caroline Cueff de Monchy; Nicolas Piriou; Romain Capoulade; Jean-Michel Serfaty; Guillaume Guimbretière; Etienne Dantan; Alejandro Ruiz-Majoral; Guénola Coste du Fou; Shani Leviatan Ben-Arye; Liana Govani; Sharon Yehuda; Shirley Bachar Abramovitch; Ron Amon; Eliran Moshe Reuven; Yafit Atiya-Nasagi; Hai Yu; Laura Iop; Kelly Casós; Sebastián G Kuguel; Arnau Blasco-Lucas; Eduard Permanyer; Fabrizio Sbraga; Roger Llatjós; Gabriel Moreno-Gonzalez; Melchor Sánchez-Martínez; Michael E Breimer; Jan Holgersson; Susann Teneberg; Marta Pascual-Gilabert; Alfons Nonell-Canals; Yasuhiro Takeuchi; Xi Chen; Rafael Mañez; Jean-Christian Roussel; Jean-Paul Soulillou; Emanuele Cozzi; Vered Padler-Karavani
Journal:  Nat Med       Date:  2022-02-17       Impact factor: 87.241

4.  Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS.

Authors:  Kayluz F Boligan; Johanna Oechtering; Christian W Keller; Benjamin Peschke; Robert Rieben; Nicolai Bovin; Ludwig Kappos; Richard D Cummings; Jens Kuhle; Stephan von Gunten; Jan D Lünemann
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-02-03

5.  Unique repertoire of anti-carbohydrate antibodies in individual human serum.

Authors:  Ralph N D Luetscher; Tanya R McKitrick; Chao Gao; Akul Y Mehta; Alyssa M McQuillan; Robert Kardish; Kayluz Frias Boligan; Xuezheng Song; Lenette Lu; Jamie Heimburg-Molinaro; Stephan von Gunten; Galit Alter; Richard D Cummings
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.